Title: Letter to the Editor regarding Peto T; UK COVID-19 Lateral Flow Oversight Team: COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay
Abstract:It is essential that studies of the accuracy of lateral flow antigen tests (LFTs) to detect SARS-CoV-2 are accurately and completely reported and that data are widely available and freely shared to en...It is essential that studies of the accuracy of lateral flow antigen tests (LFTs) to detect SARS-CoV-2 are accurately and completely reported and that data are widely available and freely shared to ensure public and health policy are properly informed [1]. The FDA have raised concerns on the evidence for the Innova LFT [2]. Peto report key studies from Porton Down and the University of Oxford which form the evidence base for use of Innova and its rebranded version (the NHS Test-and-Trace LFT) [3].Read More